Zurab Surviladze

Title: Innovations and Contributions of Zurab Surviladze

Introduction

Zurab Surviladze is a prominent inventor based in Albuquerque, NM (US). He has made significant contributions to the field of biotechnology, particularly in the development of modulators for GTPases. With a total of 8 patents, his work has the potential to impact various medical treatments.

Latest Patents

One of his latest patents focuses on "Modulators of GTPases and their use." This invention relates to molecules that function as modulators, including inhibitors and agonists, of the Ras-homologous (Rho) family of small GTPases such as Rac, Cdc42, and Rho GTPases. These modulators are designed to treat diseases, including various cancers like medulloblastoma, ovarian, breast, head and neck, testicular, and prostate cancers, as well as hematologic malignancies like B cell lymphoma. Additionally, the invention addresses sporadic and genetic diseases where the activation of Rho GTPases plays a crucial role, including Menkes disease, rheumatoid arthritis, atherosclerosis, type I diabetes, Huntington's disease, and Alzheimer's disease. The compounds developed may also serve as therapies for treating infections.

Career Highlights

Zurab Surviladze has worked with notable organizations such as UNM Rainforest Innovations and STC.UNM. His career reflects a commitment to advancing medical science through innovative research and development.

Collaborations

He has collaborated with esteemed colleagues, including Larry A. Sklar and Angela Wandinger-Ness, contributing to a rich environment of scientific inquiry and innovation.

Conclusion

Zurab Surviladze's work exemplifies the intersection of innovation and medical science, showcasing the potential of his inventions to address critical health challenges. His contributions continue to pave the way for future advancements in biotechnology.